Indian drug companies are increasing their presence in the insulin market. They are competing with multinational corporations ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

Eli Lilly and Company ( NYSE: LLY) BofA Securities 2025 Health Care Conference Call May 15, 2025 11:40 AM ET Lucas Montarce - CFO Mike Czapar - SVP, IR ...

A new report from the Access to Medicine Foundation has revealed a deepening crisis in access to diabetes care for children ...

A partial phase out of a top insulin product by Danish drug maker Novo Nordisk may ... had sent out the missive that had doctors and patients alarmed. It said some pen-filled ...

Eli Lilly is paying $13 million upfront, with $1 billion in biobucks up for grabs, for the opportunity to develop AI-designed oligonucleotide therapies from Creyon Bio. Oligonucleotides work as ...

Insulin pumps are wearable devices that people with diabetes use to deliver insulin. They are connected to a spot on your body and continuously give insulin for 2 to 4 days. An insulin pump is a ...

With type 1 diabetes, the pancreas does not produce insulin because the body’s immune system attacks the cells that make it. Therefore, a person with type 1 diabetes needs to take additional ...

Medical Dialogues had earlier reported that Novo Nordisk is phasing out several pen ... insulin brand in India showing Lupin’s consistent presence and growing acceptance among healthcare providers.

Right: Medtronic’s MiniMed 780G. [Image courtesy of the companies] Medtronic (NYSE:MDT) announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Thirty-seven-year-old Nupur Lalvani, who has been living with Type 1 diabetes since the age of eight, was dependent on insulin pens and had of late been a regular user of Novo Nordisk’s largest ...